Gerresheimer AG (ETR:GXI)
20.58
-0.16 (-0.77%)
At close: Mar 27, 2026
Gerresheimer AG Revenue
Gerresheimer AG had revenue of 560.68M EUR in the quarter ending August 31, 2025, with 12.47% growth. This brings the company's revenue in the last twelve months to 2.25B, up 11.83% year-over-year. In the fiscal year ending November 30, 2024, Gerresheimer AG had annual revenue of 2.04B with 2.28% growth.
Revenue (ttm)
2.25B
Revenue Growth
+11.83%
P/S Ratio
0.32
Revenue / Employee
166.26K
Employees
13,535
Market Cap
710.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 2.04B | 45.42M | 2.28% |
| Nov 30, 2023 | 1.99B | 173.39M | 9.54% |
| Nov 30, 2022 | 1.82B | 319.09M | 21.30% |
| Nov 30, 2021 | 1.50B | 79.22M | 5.58% |
| Nov 30, 2020 | 1.42B | 26.53M | 1.91% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Redcare Pharmacy NV | 2.94B |
| Medios AG | 2.08B |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.97B |
| Evotec SE | 756.33M |
Gerresheimer AG News
- 9 days ago - Silgan Holdings (SLGN) Eyes Acquisition of Gerresheimer - GuruFocus
- 18 days ago - Gerresheimer delays 2025 results release to June, stock to be removed from SDAX - Reuters
- 19 days ago - EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting - Wallstreet:Online
- 4 weeks ago - EQS-Adhoc: Gerresheimer AG: BaFin announces expansion of audit of 2024 consolidated financial statements and initiation of audit of 2025 Half-Year Financial Report - Wallstreet:Online
- 5 months ago - Gerresheimer appoints Uwe Röhrhoff as new interim CEO - Reuters
- 5 months ago - Gerresheimer finds 2024 revenue-recognition issues after external probe - Reuters
- 6 months ago - Gerresheimer's shares fall 11% after another outlook cut - Reuters
- 6 months ago - Gerresheimer cuts 2025 outlook again as Q3 disappoints - Reuters